TULP11 Antibody

What is TULP11 and what biological functions does it serve?

TULP11 (Tubby-like F-box protein 11) is a member of the tubby-like protein family. In Arabidopsis thaliana, it is also known as AtTLP11 and is encoded by the gene At5g18680 . The tubby-like protein family is characterized by a highly conserved C-terminal tubby domain, which is involved in phosphoinositide binding. TULP11, specifically in Arabidopsis, has a molecular weight of approximately 43,051 Da and contains characteristic F-box domains that suggest involvement in protein-protein interactions, particularly in ubiquitin-mediated protein degradation pathways . Research has indicated potential involvement of AtTLPs, including TULP11, in Arabidopsis-Piriformospora indica interaction, suggesting roles in plant-microbe signaling networks .

What are the structural characteristics of TULP11 proteins?

TULP11 proteins contain a characteristic tubby domain at the C-terminus, which forms a closed β-barrel with a central α-helix. This structure enables binding to specific phosphoinositides in cell membranes. In Arabidopsis thaliana TULP11, the protein additionally contains an F-box domain, which typically functions in substrate recognition for ubiquitin-protein ligase complexes . The complete protein structure includes regions responsible for protein-protein interactions that may regulate its cellular localization and functional activity. Three-dimensional structural information for TULP11 (UniProt accession Q6NPQ1) is available through ModBase, providing researchers with insights into potential binding sites and functional domains that can inform experimental design .

In which species and tissues has TULP11 expression been documented?

TULP11 expression has been primarily documented in Arabidopsis thaliana (Mouse-ear cress), where it shows tissue-specific expression patterns . According to the available research data, TULP11 has been notably detected in root tissues, with more than one publication associating TULP11 with root biology . The protein may play specialized roles in root development or root-associated physiological processes, including potential involvement in plant-microbe interactions. Researchers investigating TULP11 in different plant tissues should consider these expression patterns when designing experiments to ensure appropriate tissue sampling and experimental controls.

What types of TULP11 antibodies are available and how should researchers select the appropriate one?

Researchers have access to several types of TULP11 antibodies, including polyclonal antibodies such as the Rabbit anti-Arabidopsis thaliana TULP11 Polyclonal Antibody . When selecting an appropriate antibody, researchers should consider several factors:

• Target species specificity (e.g., Arabidopsis thaliana-specific)

• Clonality (polyclonal vs. monoclonal)

• Host species (rabbit, mouse, etc.)

• Validated applications (ELISA, Western Blot, IHC, etc.)

• Immunogen information (recombinant protein vs. synthetic peptide)

For instance, the anti-TULP11 antibody described in the search results is a rabbit polyclonal antibody generated against recombinant Arabidopsis thaliana TULP11 protein, making it suitable for ELISA and Western Blot applications in Arabidopsis research . Researchers should align their experimental requirements with these characteristics to ensure optimal performance.

How can researchers validate the specificity of TULP11 antibodies?

Validating antibody specificity is crucial for generating reliable research data. For TULP11 antibodies, researchers should implement a multi-step validation process:

• Positive and negative controls: Use samples with known TULP11 expression levels alongside samples where TULP11 is absent or downregulated.

• Western blot analysis: Confirm that the antibody detects a protein of the expected molecular weight (approximately 43 kDa for Arabidopsis TULP11) .

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide/protein to confirm that this blocks specific binding.

• Knockdown/knockout validation: Test antibody reactivity in TULP11 knockdown or knockout samples to verify specificity.

• Cross-reactivity assessment: Evaluate potential cross-reactivity with related tubby-like proteins, particularly if working in systems with multiple TLP family members.

These validation steps ensure that experimental observations truly reflect TULP11 biology rather than non-specific interactions or cross-reactivity with related proteins.

What are the recommended storage and handling conditions for TULP11 antibodies?

Proper storage and handling of TULP11 antibodies are essential for maintaining their functionality and specificity. Based on standard protocols for similar antibodies, researchers should:

• Store antibodies at -20°C or -80°C for long-term storage to prevent degradation .

• Avoid repeated freeze-thaw cycles, which can significantly reduce antibody activity. Aliquoting the antibody upon receipt is strongly recommended .

• For the specific anti-TULP11 antibody mentioned in the search results, it is supplied in a liquid form containing 50% Glycerol and 0.03% Proclin 300 in 0.01M PBS (pH 7.4), which helps maintain stability during storage .

• If liquid becomes entrapped in the seal of the product vial during shipment, briefly centrifuge the vial to collect the liquid at the bottom .

• When working with the antibody, maintain cold chain practices and handle on ice when possible to preserve activity.

• Follow manufacturer-specific recommendations for dilution factors in different applications to ensure optimal signal-to-noise ratios.

How should researchers optimize Western blot protocols for TULP11 detection?

Optimizing Western blot protocols for TULP11 detection requires attention to several key factors:

• Sample preparation: Extract proteins using buffers containing appropriate protease inhibitors to prevent degradation of TULP11. For Arabidopsis samples, specialized plant protein extraction buffers containing PVPP to remove phenolics may improve results.

• Loading controls: Include appropriate loading controls relevant to the experimental system (e.g., actin or tubulin for Arabidopsis samples).

• Blocking conditions: Optimize blocking solutions (typically 3-5% BSA or non-fat milk) to minimize background while maintaining specific signal.

• Antibody dilution: Start with the manufacturer's recommended dilution of anti-TULP11 antibody (typically 1:500 to 1:2000) and optimize as needed .

• Incubation conditions: Test both overnight incubation at 4°C and shorter incubations at room temperature to determine optimal conditions.

• Detection method: Choose an appropriate secondary antibody (anti-rabbit IgG for the polyclonal antibody described) conjugated to HRP, fluorophore, or other detection systems based on available equipment and sensitivity requirements.

• Controls: Include positive controls (tissues known to express TULP11, such as Arabidopsis roots) and negative controls to validate results .

What are the key considerations for using TULP11 antibodies in ELISA applications?

When using TULP11 antibodies in ELISA applications, researchers should consider these methodological aspects:

• Coating conditions: Determine optimal antigen or antibody coating concentration and buffer conditions. For direct ELISA, coating plates with 1-10 μg/ml of sample protein in carbonate buffer (pH 9.6) is typically effective.

• Blocking parameters: Test different blocking agents (BSA, casein, or commercial blocking buffers) to minimize background while preserving specific signal.

• Antibody titration: Perform titration experiments with the anti-TULP11 antibody to determine the optimal working dilution that provides maximum specific signal with minimal background.

• Sample preparation: For plant samples, specialized extraction procedures may be necessary to remove compounds that could interfere with antibody binding.

• Standard curve development: If quantifying TULP11, develop a standard curve using recombinant TULP11 protein across a relevant concentration range.

• Detection system selection: Choose appropriate enzyme-conjugated secondary antibodies and substrates based on required sensitivity (HRP with TMB substrate is commonly used).

• Validation: Include positive and negative controls to verify assay specificity and performance.

• Data analysis: Establish appropriate curve-fitting models for quantification of TULP11 in unknown samples.

Can TULP11 antibodies be effectively used in immunohistochemistry or immunofluorescence studies?

While the search results specifically validate the anti-TULP11 antibody for ELISA and Western Blot applications , researchers interested in immunohistochemistry (IHC) or immunofluorescence (IF) studies should consider the following:

• Preliminary validation: Before proceeding with full experiments, conduct preliminary validation studies to confirm antibody performance in IHC/IF applications, as not all antibodies that work in Western blot will work in these contexts.

• Fixation optimization: Test multiple fixation methods (paraformaldehyde, glutaraldehyde, or combinations) to determine which best preserves TULP11 antigenicity while maintaining tissue morphology.

• Antigen retrieval: For plant tissues, evaluate different antigen retrieval methods (heat-induced, enzymatic) to enhance antibody accessibility to the target.

• Permeabilization: Optimize detergent concentration and incubation time to ensure antibody penetration without destroying tissue architecture.

• Blocking protocol: Develop a robust blocking protocol to minimize non-specific binding, particularly important in plant tissues that may contain endogenous peroxidases or phosphatases.

• Controls: Include appropriate controls, including:

  • Primary antibody omission control

  • Isotype control (irrelevant antibody of same isotype)

  • Tissue with known TULP11 expression patterns

  • Pre-absorption control with immunizing peptide

• Counterstaining: Select appropriate counterstains compatible with the detection method to provide tissue context for TULP11 localization.

How can researchers combine TULP11 antibody techniques with other molecular biology approaches for comprehensive pathway analysis?

Integrating TULP11 antibody techniques with complementary molecular approaches enables comprehensive pathway analysis:

• Co-immunoprecipitation (Co-IP): Use anti-TULP11 antibodies to pull down TULP11 protein complexes, followed by mass spectrometry to identify interaction partners, particularly relevant given TULP11's F-box domain and potential role in protein-protein interactions .

• Chromatin immunoprecipitation (ChIP): If TULP11 has nuclear functions, ChIP using anti-TULP11 antibodies can identify DNA binding sites or associated chromatin regions.

• Proximity labeling: Combine antibody validation with proximity labeling approaches (BioID, APEX) to identify transient or weak TULP11 interaction partners in living cells.

• RNA-seq with protein validation: Correlate transcriptomic data with protein-level validation using anti-TULP11 antibodies to understand expression regulation.

• CRISPR-Cas9 genome editing: Generate TULP11 knockout or tagged lines, then use antibodies to confirm editing efficiency and study phenotypic consequences.

• Multi-omics integration: Combine proteomics data obtained using anti-TULP11 antibodies with transcriptomics, metabolomics, and phenomics data for systems-level understanding of TULP11 function.

• Super-resolution microscopy: Use fluorescently labeled anti-TULP11 antibodies with super-resolution techniques to precisely localize TULP11 within subcellular compartments.

These integrated approaches move beyond simple protein detection to comprehensively understand TULP11's role in biological pathways.

What strategies can be employed to investigate TULP11's role in Arabidopsis-Piriformospora indica interactions?

To investigate TULP11's role in Arabidopsis-Piriformospora indica interactions, researchers can implement several strategic approaches:

• Expression profiling: Use anti-TULP11 antibodies in Western blot or ELISA to quantify changes in TULP11 protein levels during different stages of Arabidopsis-P. indica interaction .

• Localization studies: Employ immunofluorescence with anti-TULP11 antibodies to track TULP11 subcellular localization before and after P. indica colonization.

• Genetic manipulation:

  • Create TULP11 overexpression and knockout lines

  • Evaluate P. indica colonization efficiency in these lines

  • Use anti-TULP11 antibodies to confirm alteration of protein levels

• Protein-protein interaction studies:

  • Conduct co-immunoprecipitation with anti-TULP11 antibodies during P. indica colonization

  • Identify potential interaction partners from both plant and fungal origin

  • Confirm interactions using reciprocal co-IP or other validation methods

• Phosphorylation state analysis: Use phospho-specific antibodies (if available) or mass spectrometry following TULP11 immunoprecipitation to determine if P. indica colonization alters TULP11 phosphorylation.

• Comparative studies: Analyze TULP11 function in comparison with other AtTLPs already implicated in Arabidopsis-P. indica interactions .

• Field validation: Translate laboratory findings to more natural settings to confirm biological relevance of TULP11 in plant-microbe interactions.

How does the choice of antibody production method affect experimental outcomes with TULP11 antibodies?

The method used to produce antibodies against TULP11 can significantly impact experimental outcomes:

• Hybridoma technology: This established method produces mouse monoclonal antibodies with consistent specificity but may have immunogenicity issues when used in vivo . For TULP11 research, hybridoma-derived antibodies would provide highly reproducible results in applications like Western blot and ELISA.

• B cell immortalization: This approach maintains natural antibody pairing and produces fully human antibodies, which is advantageous for therapeutic applications but less critical for most TULP11 research applications . The ability to preserve the characteristics of the original B cell makes this approach valuable for specialized applications.

• Phage display: This technique can generate antibody fragments (scFv or Fab) with high specificity, though H and L chain pairing may not represent in vivo antibody pairing . For TULP11 research, phage display-derived antibodies might offer high specificity but could lack some post-translational modifications found in mammalian-produced antibodies.

• Ribosome display: This cell-free system can screen extremely large libraries (10^12-10^15 members) and is particularly useful for scFv optimization . For TULP11 applications requiring extraordinarily high affinity or specificity, ribosome display might be advantageous.

• Mammalian cell display: This method provides increased expression, stability, and functionally glycosylated antibodies . For applications requiring native post-translational modifications of anti-TULP11 antibodies, this approach may yield superior results.

The polyclonal anti-TULP11 antibody described in the search results was produced using recombinant Arabidopsis thaliana TULP11 protein as the immunogen , likely using traditional immunization approaches that yield polyclonal antibodies with broad epitope recognition but potential batch-to-batch variation.

What are common challenges in TULP11 antibody-based experiments and how can they be addressed?

Researchers working with TULP11 antibodies may encounter several challenges that require specific troubleshooting approaches:

• Low signal intensity in Western blot:

  • Increase antibody concentration or incubation time

  • Optimize protein extraction to increase TULP11 yield

  • Use more sensitive detection methods (e.g., enhanced chemiluminescence)

  • Ensure that small volumes of antibody have not become entrapped in the seal of the product vial

• High background:

  • Increase blocking concentration or time

  • Use alternative blocking agents (BSA, casein, commercial blockers)

  • Increase wash duration and frequency

  • Titrate primary antibody to optimal concentration

  • Verify secondary antibody specificity

• Non-specific bands:

  • Increase antibody specificity through affinity purification

  • Optimize sample preparation to reduce protein degradation

  • Include appropriate controls (TULP11 knockout/knockdown)

  • Consider using monoclonal antibodies if polyclonal shows cross-reactivity

• Inconsistent results:

  • Standardize experimental protocols

  • Maintain consistent antibody lot numbers when possible

  • Implement positive controls in each experiment

  • Ensure proper storage of antibodies to prevent degradation

• Poor reproducibility in plant tissues:

  • Modify extraction buffers to account for plant-specific compounds

  • Add protease inhibitors appropriate for plant proteases

  • Consider extraction timing (diurnal variations may affect results)

  • Standardize plant growth conditions to reduce biological variability

How can researchers quantitatively analyze TULP11 expression levels in different experimental contexts?

Quantitative analysis of TULP11 expression requires rigorous methodological approaches:

• Western blot densitometry:

  • Use linear range of detection for both TULP11 and loading control

  • Apply appropriate normalization (typically to housekeeping proteins)

  • Utilize digital image analysis software with background subtraction

  • Include calibration standards when possible

  • Report results as fold-change relative to control conditions

• Quantitative ELISA:

  • Develop standard curves using recombinant TULP11 protein

  • Ensure samples fall within the linear range of the standard curve

  • Account for matrix effects in different sample types

  • Include technical replicates (minimum triplicate measurements)

  • Validate results with orthogonal methods (e.g., Western blot)

• Flow cytometry (for cellular analysis):

  • Optimize cell fixation and permeabilization protocols

  • Titrate antibody concentration for optimal signal-to-noise ratio

  • Include fluorescence-minus-one (FMO) controls

  • Use median fluorescence intensity (MFI) for quantification

  • Consider dual-parameter analysis to account for cell size/complexity

• Immunohistochemistry quantification:

  • Use standardized image acquisition parameters

  • Apply automated image analysis algorithms

  • Quantify staining intensity, area, or distribution patterns

  • Include reference standards in each batch

  • Account for tissue-specific autofluorescence or background

• Multiplexed analysis:

  • Combine TULP11 detection with other relevant proteins

  • Use antibodies with compatible species and isotypes

  • Apply spectral unmixing if using fluorescent detection

  • Validate that multiplexing doesn't affect individual antibody performance

What quality control measures should be implemented when using TULP11 antibodies in long-term research projects?

For long-term research projects using TULP11 antibodies, implementing robust quality control measures is essential:

• Antibody validation schedule:

  • Initially validate each new lot of antibody

  • Perform periodic revalidation (every 3-6 months)

  • Document validation results systematically

  • Include positive control samples in validation tests

• Storage and handling protocols:

  • Maintain proper storage conditions (-20°C or -80°C)

  • Aliquot antibodies to minimize freeze-thaw cycles

  • Document date of first use and thawing for each aliquot

  • Monitor storage equipment (freezers, refrigerators) with temperature logs

• Standard operating procedures (SOPs):

  • Develop detailed SOPs for all TULP11 antibody applications

  • Train all personnel according to SOPs

  • Update SOPs based on validation outcomes

  • Implement version control for protocol modifications

• Reference standards:

  • Maintain stable reference samples (positive controls)

  • Include calibration standards in quantitative assays

  • Consider developing internal reference materials

  • Document batch information for all standards

• Data management:

  • Establish consistent data recording formats

  • Implement regular data backup procedures

  • Maintain complete experimental metadata

  • Use laboratory information management systems when possible

• Antibody characterization documentation:

  • Maintain detailed records of antibody specifications

  • Document lot-to-lot variations

  • Record performance in different applications

  • Create a database of experimental conditions and outcomes

What emerging technologies might enhance TULP11 antibody research?

Several emerging technologies have the potential to significantly advance TULP11 antibody research:

• Single-cell proteomics: Applying single-cell resolution to TULP11 protein analysis could reveal cell-type specific expression patterns and functions that might be masked in bulk tissue analysis.

• Antibody engineering: Using techniques like CDR grafting or directed evolution to develop highly specific monoclonal antibodies against TULP11, potentially overcoming cross-reactivity issues with other tubby-like proteins .

• Spatially-resolved proteomics: Technologies like Imaging Mass Cytometry or CODEX could allow visualization of TULP11 expression patterns in complex tissues while simultaneously measuring dozens of other proteins.

• Protein-protein interaction mapping: Advanced techniques like BioID, APEX proximity labeling, or cross-linking mass spectrometry combined with TULP11 antibodies could comprehensively map TULP11 interaction networks.

• Cryo-electron microscopy: Using anti-TULP11 antibodies for immunoprecipitation followed by cryo-EM analysis could reveal detailed structural information about TULP11 and its complexes.

• Nanobody development: Developing camelid single-domain antibodies (nanobodies) against TULP11 could provide improved access to cryptic epitopes and enhanced performance in certain applications.

• Optogenetic antibody control: Light-controlled antibody systems could allow precise temporal control of TULP11 binding or inhibition in live cell systems.

How might comparative studies of TULP11 across different plant species advance our understanding of plant immunity?

Comparative studies of TULP11 across different plant species represents a promising research direction:

• Evolutionary analysis: Using anti-TULP11 antibodies that recognize conserved epitopes to study TULP11 homologs across diverse plant species could reveal evolutionary patterns in tubby-like protein function.

• Functional conservation assessment: Comparing TULP11's role in Arabidopsis-Piriformospora indica interactions with homologous proteins in other plant-microbe systems could identify conserved immune functions .

• Structural diversification: Analyzing species-specific differences in TULP11 structure and post-translational modifications might explain host-specific responses to pathogens or symbionts.

• Crop improvement applications: Translating findings from model plants to agriculturally important species could lead to enhanced disease resistance or beneficial microbial associations.

• Development of cross-reactive tools: Creating antibodies that recognize conserved TULP11 epitopes across multiple species would facilitate comparative studies without needing species-specific reagents.

• Systems-level integration: Comparing TULP11-centered protein interaction networks across species could identify core and variable components of plant immune responses.

• Environmental adaptation insights: Studying TULP11 function across plants adapted to different environments might reveal specialized roles in stress responses or environmental adaptation.

What are the potential implications of TULP11 research for agricultural applications?

Research on TULP11 has several potential agricultural applications:

• Enhanced beneficial microbial associations: Understanding TULP11's role in Arabidopsis-Piriformospora indica interactions could lead to strategies for enhancing beneficial plant-microbe relationships in crops .

• Improved disease resistance: If TULP11 is involved in immune signaling pathways, modulating its expression or activity might enhance crop resistance to pathogens.

• Root development optimization: Given TULP11's expression in root tissues, research might reveal methods to optimize root architecture or function for improved nutrient acquisition or drought resistance .

• Biomarker development: TULP11 protein levels or modifications could potentially serve as biomarkers for plant stress responses or microbial colonization status.

• Transgenic approaches: Engineering TULP11 expression or developing synthetic TULP11 variants could potentially enhance beneficial traits in agricultural crops.

• Breeding program screening: Antibody-based assays for TULP11 could potentially be used to screen breeding lines for desired protein expression patterns associated with beneficial traits.

• Sustainable agriculture practices: Understanding molecular mechanisms involving TULP11 might inform practices that enhance natural plant defenses or beneficial microbial associations, potentially reducing chemical input requirements.